Propranolol and survival from breast cancer: a pooled analysis of European breast cancer cohorts

BACKGROUND: Preclinical studies have demonstrated that propranolol inhibits several pathways involved in breast cancer progression and metastasis. We investigated whether breast cancer patients who used propranolol, or other non-selective beta-blockers, had reduced breast cancer-specific or all-caus...

Descripción completa

Detalles Bibliográficos
Autores principales: Cardwell, Chris R., Pottegård, Anton, Vaes, Evelien, Garmo, Hans, Murray, Liam J., Brown, Chris, Vissers, Pauline A. J., O’Rorke, Michael, Visvanathan, Kala, Cronin-Fenton, Deirdre, De Schutter, Harlinde, Lambe, Mats, Powe, Des G., van Herk-Sukel, Myrthe P. P., Gavin, Anna, Friis, Søren, Sharp, Linda, Bennett, Kathleen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5133766/
https://www.ncbi.nlm.nih.gov/pubmed/27906047
http://dx.doi.org/10.1186/s13058-016-0782-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5133766/
https://www.ncbi.nlm.nih.gov/pubmed/27906047
http://dx.doi.org/10.1186/s13058-016-0782-5

Ejemplares similares